Welcome & Introduction by Dr. Divesh Goyal | Oncology Perspective 2024 | Day 2

New Updates in 1st Line BTC Management by Dr. Pulkit Nag | Oncology Perspective 2024

Ovarian Cancer & PARP Inhibitors with Dr. B.S. Ankit Nehra | Oncology Perspective 2024

Management of Metastatic Urothelial Cancer with Dr. Aseem Samar | Oncology Perspective 2024

Integrating Adjuvant CDK4/6 Therapy for HR+/Her2- EBC | Dr. Naresh Somani | Oncology 2024

Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer | Dr. Jitendra Pahlajani

Managing HR+/HER2- & TNBC: Panel Discussion | Dr. Stalin Chowdary Bala & Experts | Oncology 2024

Closing Remarks by Dr. Divesh Goyal | Oncology Perspective 2024 | Day 2